Connection

ALAN SWANN to Female

This is a "connection" page, showing publications ALAN SWANN has written about Female.
Connection Strength

0.717
  1. Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis. CNS Spectr. 2017 Apr; 22(2):228-235.
    View in: PubMed
    Score: 0.020
  2. Trait impulsivity and increased pre-attentional sensitivity to intense stimuli in bipolar disorder and controls. J Psychiatr Res. 2015 Jan; 60:73-80.
    View in: PubMed
    Score: 0.017
  3. Pre-attentive information processing and impulsivity in bipolar disorder. J Psychiatr Res. 2013 Dec; 47(12):1917-24.
    View in: PubMed
    Score: 0.015
  4. Norepinephrine and impulsivity: effects of acute yohimbine. Psychopharmacology (Berl). 2013 Sep; 229(1):83-94.
    View in: PubMed
    Score: 0.015
  5. Addictive disorders: finding the predisposing traits. Am J Psychiatry. 2012 Sep; 169(9):888-90.
    View in: PubMed
    Score: 0.014
  6. Multivariate analysis of bipolar mania: retrospectively assessed structure of bipolar I manic and mixed episodes in randomized clinical trial participants. J Affect Disord. 2013 Jan 10; 144(1-2):59-64.
    View in: PubMed
    Score: 0.014
  7. Antisocial personality disorder and borderline symptoms are differentially related to impulsivity and course of illness in bipolar disorder. J Affect Disord. 2013 Jun; 148(2-3):384-90.
    View in: PubMed
    Score: 0.014
  8. Criminal conviction, impulsivity, and course of illness in bipolar disorder. Bipolar Disord. 2011 Mar; 13(2):173-81.
    View in: PubMed
    Score: 0.013
  9. Sensation seeking, risk behaviors, and alcohol consumption among Mexican origin youth. J Adolesc Health. 2011 Jan; 48(1):65-72.
    View in: PubMed
    Score: 0.013
  10. Interactions between bipolar disorder and antisocial personality disorder in trait impulsivity and severity of illness. Acta Psychiatr Scand. 2010 Jun; 121(6):453-61.
    View in: PubMed
    Score: 0.012
  11. Pharmacologic mood destabilization: case vignettes. CNS Spectr. 2009 Nov; 14(11 Suppl 11):9-11; discussion 12-4.
    View in: PubMed
    Score: 0.012
  12. P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory. Psychophysiology. 2009 Sep; 46(5):1059-68.
    View in: PubMed
    Score: 0.011
  13. Increased trait-like impulsivity and course of illness in bipolar disorder. Bipolar Disord. 2009 May; 11(3):280-8.
    View in: PubMed
    Score: 0.011
  14. Diminished P50, N100 and P200 auditory sensory gating in bipolar I disorder. Psychiatry Res. 2009 May 30; 167(3):191-201.
    View in: PubMed
    Score: 0.011
  15. A pilot study revealing impaired P50 gating in antisocial personality disorder. J Neuropsychiatry Clin Neurosci. 2009; 21(3):328-31.
    View in: PubMed
    Score: 0.011
  16. Severity of bipolar disorder is associated with impairment of response inhibition. J Affect Disord. 2009 Jul; 116(1-2):30-6.
    View in: PubMed
    Score: 0.011
  17. High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression? Transl Psychiatry. 2026 Jul 04; 16(1).
    View in: PubMed
    Score: 0.009
  18. Mitigating Post-Traumatic Stress Disorder Risk Through Gender-Sensitive Trauma-Informed Care in the Emergency Department-A Narrative Review. J Emerg Med. 2026 01; 80:241-251.
    View in: PubMed
    Score: 0.009
  19. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry. 2005 Sep; 162(9):1680-7.
    View in: PubMed
    Score: 0.009
  20. Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol Psychiatry. 2005 May 15; 57(10):1209-11.
    View in: PubMed
    Score: 0.009
  21. The association between cannabis use and suicidal intensity in psychiatric inpatients. Am J Addict. 2025 Sep; 34(5):506-516.
    View in: PubMed
    Score: 0.009
  22. Effects of the KCNQ (Kv7) Channel Opener Ezogabine on Resting-State Functional Connectivity of Striatal Brain Reward Regions, Depression, and Anhedonia in Major Depressive Disorder: Results From a Randomized Controlled Trial. Biol Psychiatry. 2025 Oct 01; 98(7):568-577.
    View in: PubMed
    Score: 0.009
  23. Long-term treatment in bipolar disorder. J Clin Psychiatry. 2005; 66 Suppl 1:7-12.
    View in: PubMed
    Score: 0.008
  24. Use of Cigarettes and E-Cigarettes, Impulsivity, and Anxiety: Influences on Suicidal Ideation Among Youth and Young Adults in Texas. Nicotine Tob Res. 2024 12 23; 27(1):54-60.
    View in: PubMed
    Score: 0.008
  25. Involvement in physical activity and risk for nearly lethal suicide attempts. Am J Prev Med. 2004 Nov; 27(4):310-5.
    View in: PubMed
    Score: 0.008
  26. Impulsivity: a link between bipolar disorder and substance abuse. Bipolar Disord. 2004 Jun; 6(3):204-12.
    View in: PubMed
    Score: 0.008
  27. Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Mol Psychiatry. 2024 08; 29(8):2399-2407.
    View in: PubMed
    Score: 0.008
  28. P300 event-related potential amplitude and impulsivity in cocaine-dependent subjects. Neuropsychobiology. 2004; 50(2):167-73.
    View in: PubMed
    Score: 0.008
  29. Anti-suicidal effects of IV ketamine in a real-world setting. Psychiatry Res. 2024 01; 331:115604.
    View in: PubMed
    Score: 0.008
  30. Behavioral impulsivity paradigms: a comparison in hospitalized adolescents with disruptive behavior disorders. J Child Psychol Psychiatry. 2003 Nov; 44(8):1145-57.
    View in: PubMed
    Score: 0.008
  31. Differentiating anxiety and depression in older adults with generalized anxiety disorder. Psychol Assess. 2003 Jun; 15(2):184-92.
    View in: PubMed
    Score: 0.008
  32. Impulsivity and phase of illness in bipolar disorder. J Affect Disord. 2003 Jan; 73(1-2):105-11.
    View in: PubMed
    Score: 0.007
  33. Familial transmission of Continuous Performance Test behavior: attentional and impulsive response characteristics. J Gen Psychol. 2003 Jan; 130(1):5-21.
    View in: PubMed
    Score: 0.007
  34. Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol Depend. 2002 Sep 01; 68(1):105-11.
    View in: PubMed
    Score: 0.007
  35. Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry. 2002 Jun 15; 51(12):988-94.
    View in: PubMed
    Score: 0.007
  36. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology. 2002 Apr; 26(4):530-6.
    View in: PubMed
    Score: 0.007
  37. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J Affect Disord. 2001 Dec; 67(1-3):123-32.
    View in: PubMed
    Score: 0.007
  38. Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial. Neuropsychopharmacology. 2022 04; 47(5):1088-1095.
    View in: PubMed
    Score: 0.007
  39. Endogenous plasma testosterone levels and commission errors in women: A preliminary report. Physiol Behav. 2001 May; 73(1-2):217-21.
    View in: PubMed
    Score: 0.007
  40. Measurement of inter-episode impulsivity in bipolar disorder. Psychiatry Res. 2001 Mar 25; 101(2):195-7.
    View in: PubMed
    Score: 0.006
  41. Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial. Am J Psychiatry. 2021 05 01; 178(5):437-446.
    View in: PubMed
    Score: 0.006
  42. Major system toxicities and side effects of anticonvulsants. J Clin Psychiatry. 2001; 62 Suppl 14:16-21.
    View in: PubMed
    Score: 0.006
  43. A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-D-aspartate receptor blockade in healthy veterans. Neuropsychopharmacology. 2021 03; 46(4):820-827.
    View in: PubMed
    Score: 0.006
  44. Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans. Psychoneuroendocrinology. 2000 Aug; 25(6):607-18.
    View in: PubMed
    Score: 0.006
  45. ECT in mixed affective states: a case series. J ECT. 2000 Jun; 16(2):183-8.
    View in: PubMed
    Score: 0.006
  46. Mania: differential effects of previous depressive and manic episodes on response to treatment. Acta Psychiatr Scand. 2000 Jun; 101(6):444-51.
    View in: PubMed
    Score: 0.006
  47. Generalized anxiety disorder in older adults: examining the relation between clinician severity ratings and patient self-report measures. Depress Anxiety. 2000; 12(4):217-25.
    View in: PubMed
    Score: 0.006
  48. Psychotherapy for Mixed Depression and Mixed Mania. Psychiatr Clin North Am. 2020 03; 43(1):199-211.
    View in: PubMed
    Score: 0.006
  49. Mania: gender, transmitter function, and response to treatment. Psychiatry Res. 1999 Oct 18; 88(1):55-61.
    View in: PubMed
    Score: 0.006
  50. Early and late cortical reactivity to passively viewed emotional faces in pediatric bipolar disorder. J Affect Disord. 2019 06 15; 253:240-247.
    View in: PubMed
    Score: 0.006
  51. Psychomotor performance and monoamine function in bipolar and unipolar affective disorders. Biol Psychiatry. 1999 Apr 15; 45(8):979-88.
    View in: PubMed
    Score: 0.006
  52. Laboratory measures of aggression and impulsivity in women with borderline personality disorder. Psychiatry Res. 1999 Mar 22; 85(3):315-26.
    View in: PubMed
    Score: 0.006
  53. Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations. Am J Psychiatry. 1999 Mar; 156(3):426-30.
    View in: PubMed
    Score: 0.006
  54. Ipsapirone neuroendocrine challenge: relationship to aggression as measured in the human laboratory. Psychiatry Res. 1998 Oct 19; 81(1):31-8.
    View in: PubMed
    Score: 0.005
  55. Droperidol in the interim management of severe mania: case reports and literature review. Clin Neuropharmacol. 1998 Sep-Oct; 21(5):316-8.
    View in: PubMed
    Score: 0.005
  56. The influence of menstrual-cycle phase on the relationship between testosterone and aggression. Physiol Behav. 1997 Aug; 62(2):431-5.
    View in: PubMed
    Score: 0.005
  57. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response. J Clin Psychopharmacol. 1997 Apr; 17(2):78-83.
    View in: PubMed
    Score: 0.005
  58. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry. 1997 Jan; 54(1):37-42.
    View in: PubMed
    Score: 0.005
  59. Psychometric properties of the MSPSS and NOS in psychiatric outpatients. J Clin Psychol. 1995 Sep; 51(5):593-602.
    View in: PubMed
    Score: 0.004
  60. Mixed mania: apparent induction by a tricyclic antidepressant in five consecutively treated patients with bipolar depression. Biol Psychiatry. 1995 Jan 01; 37(1):60-2.
    View in: PubMed
    Score: 0.004
  61. Illness-course modulates suicidality-related prefrontal gray matter reduction in women with bipolar disorder. Acta Psychiatr Scand. 2014 Nov; 130(5):374-87.
    View in: PubMed
    Score: 0.004
  62. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence. Alcohol Clin Exp Res. 2014 Jul; 38(7):2113-8.
    View in: PubMed
    Score: 0.004
  63. Genetic, psychosocial, and demographic factors associated with social disinhibition in Mexican-origin youth. Brain Behav. 2014 Jul; 4(4):521-30.
    View in: PubMed
    Score: 0.004
  64. Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function. Biol Psychiatry. 1994 May 15; 35(10):803-13.
    View in: PubMed
    Score: 0.004
  65. Impulsivity in children and adolescents with mood disorders and unaffected offspring of bipolar parents. Compr Psychiatry. 2014 Aug; 55(6):1337-41.
    View in: PubMed
    Score: 0.004
  66. Depressive mania: response of residual depression to bupropion. Biol Psychiatry. 1994 Apr 01; 35(7):493-4.
    View in: PubMed
    Score: 0.004
  67. First manic episode associated with use of human chorionic gonadotropin for obesity: a case report. Bipolar Disord. 2014 Mar; 16(2):204-7.
    View in: PubMed
    Score: 0.004
  68. Can the Yale-Brown Obsessive Compulsive Scale be used to assess trichotillomania? A preliminary report. Behav Res Ther. 1993 Feb; 31(2):171-7.
    View in: PubMed
    Score: 0.004
  69. Catatonia associated with depression secondary to complex partial epilepsy. J Clin Psychiatry. 1993 Feb; 54(2):73.
    View in: PubMed
    Score: 0.004
  70. The role of cortisol and psychopathy in the cycle of violence. Psychopharmacology (Berl). 2013 Jun; 227(4):661-72.
    View in: PubMed
    Score: 0.004
  71. Is impulsivity a common trait in bipolar and unipolar disorders? Bipolar Disord. 2013 Mar; 15(2):223-7.
    View in: PubMed
    Score: 0.004
  72. Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder. J Neuropsychiatry Clin Neurosci. 2013; 25(3):229-32.
    View in: PubMed
    Score: 0.004
  73. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry. 1992 Dec; 149(12):1633-44.
    View in: PubMed
    Score: 0.004
  74. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand. 1992 Apr; 85(4):270-4.
    View in: PubMed
    Score: 0.003
  75. Different measures of impulsivity in patients with anxiety disorders: a case control study. Psychiatry Res. 2012 May 30; 197(3):231-6.
    View in: PubMed
    Score: 0.003
  76. Does anxiety increase impulsivity in patients with bipolar disorder or major depressive disorder? J Psychiatr Res. 2012 May; 46(5):616-21.
    View in: PubMed
    Score: 0.003
  77. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry. 1992 Jan; 149(1):108-11.
    View in: PubMed
    Score: 0.003
  78. Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior. J Psychopharmacol. 2012 Jul; 26(7):982-93.
    View in: PubMed
    Score: 0.003
  79. Mania: sympathoadrenal function and clinical state. Psychiatry Res. 1991 May; 37(2):195-205.
    View in: PubMed
    Score: 0.003
  80. Repetitive methylphenidate administration modulates the diurnal behavioral activity pattern of adult female SD rats. J Neural Transm (Vienna). 2011 Feb; 118(2):285-98.
    View in: PubMed
    Score: 0.003
  81. Relationship between impulsivity and decision making in cocaine dependence. Psychiatry Res. 2010 Jul 30; 178(2):299-304.
    View in: PubMed
    Score: 0.003
  82. Zolmitriptan and human aggression: interaction with alcohol. Psychopharmacology (Berl). 2010 Jul; 210(4):521-31.
    View in: PubMed
    Score: 0.003
  83. Stress, depression, and mania: relationship between perceived role of stressful events and clinical and biochemical characteristics. Acta Psychiatr Scand. 1990 Apr; 81(4):389-97.
    View in: PubMed
    Score: 0.003
  84. Lithium distribution in mania: single-dose pharmacokinetics and sympathoadrenal function. Psychiatry Res. 1990 Apr; 32(1):71-84.
    View in: PubMed
    Score: 0.003
  85. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res. 2009 Nov; 33(11):1863-9.
    View in: PubMed
    Score: 0.003
  86. Baseline neurocognitive profiles differentiate abstainers and non-abstainers in a cocaine clinical trial. J Addict Dis. 2009 Jul; 28(3):250-7.
    View in: PubMed
    Score: 0.003
  87. Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats? Neuropharmacology. 2009 Sep; 57(3):201-7.
    View in: PubMed
    Score: 0.003
  88. Low MHPG and continuing treatment in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1989; 13(5):701-7.
    View in: PubMed
    Score: 0.003
  89. Long-term outpatient treatment of senile dementia with oral physostigmine. J Clin Psychiatry. 1988 Oct; 49(10):400-4.
    View in: PubMed
    Score: 0.003
  90. The economic and social costs of panic disorder. Hosp Community Psychiatry. 1987 Dec; 38(12):1277-9, 1288.
    View in: PubMed
    Score: 0.003
  91. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Arch Gen Psychiatry. 1987 Apr; 44(4):345-54.
    View in: PubMed
    Score: 0.002
  92. Characterizing aggressive behavior with the Impulsive/Premeditated Aggression Scale among adolescents with conduct disorder. Psychiatry Res. 2007 Jun 30; 151(3):231-42.
    View in: PubMed
    Score: 0.002
  93. Diffusion tensor imaging eigenvalues: preliminary evidence for altered myelin in cocaine dependence. Psychiatry Res. 2007 Apr 15; 154(3):253-8.
    View in: PubMed
    Score: 0.002
  94. Lithium distribution in mania: plasma and red blood cell lithium, clinical state, and monoamine metabolites during lithium treatment. Psychiatry Res. 1987 Jan; 20(1):1-12.
    View in: PubMed
    Score: 0.002
  95. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. Am J Drug Alcohol Abuse. 2007; 33(3):367-78.
    View in: PubMed
    Score: 0.002
  96. Diffusion tensor imaging in MDMA users and controls: association with decision making. Am J Drug Alcohol Abuse. 2007; 33(6):777-89.
    View in: PubMed
    Score: 0.002
  97. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry. 2006 Oct; 67(10):1501-10.
    View in: PubMed
    Score: 0.002
  98. Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res. 1986 Jun; 18(2):127-41.
    View in: PubMed
    Score: 0.002
  99. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs. 2006; 20(3):219-31.
    View in: PubMed
    Score: 0.002
  100. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. Neuropsychopharmacology. 2005 Oct; 30(10):1932-9.
    View in: PubMed
    Score: 0.002
  101. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry. 2005 Mar; 162(3):621-4.
    View in: PubMed
    Score: 0.002
  102. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2005 Mar; 66(3):323-30.
    View in: PubMed
    Score: 0.002
  103. Self-inflicted gunshot wounds: lethality of method versus intent. Am J Psychiatry. 1985 Feb; 142(2):228-31.
    View in: PubMed
    Score: 0.002
  104. Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Psychopharmacology (Berl). 1985; 87(2):147-51.
    View in: PubMed
    Score: 0.002
  105. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Curr Med Res Opin. 2004 Dec; 20(12):1883-93.
    View in: PubMed
    Score: 0.002
  106. A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants. Int J Neuropsychopharmacol. 2004 Dec; 7(4):471-9.
    View in: PubMed
    Score: 0.002
  107. A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry. 2004 Jan; 65(1):114-9.
    View in: PubMed
    Score: 0.002
  108. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology. 2003 Jul; 28(7):1374-82.
    View in: PubMed
    Score: 0.002
  109. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology. 2003 Jun; 28(6):1186-97.
    View in: PubMed
    Score: 0.002
  110. CSF monoamine metabolites in mania. Am J Psychiatry. 1983 Apr; 140(4):396-400.
    View in: PubMed
    Score: 0.002
  111. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol. 2003 Apr; 71(2):309-19.
    View in: PubMed
    Score: 0.002
  112. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. J Clin Psychiatry. 2003 Mar; 64(3):288-94.
    View in: PubMed
    Score: 0.002
  113. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2002 Dec; 63(12):1148-55.
    View in: PubMed
    Score: 0.002
  114. Laboratory-measured aggressive behavior of women: acute tryptophan depletion and augmentation. Neuropsychopharmacology. 2002 May; 26(5):660-71.
    View in: PubMed
    Score: 0.002
  115. Serotonin 2a receptor T102C polymorphism and impaired impulse control. Am J Med Genet. 2002 Apr 08; 114(3):336-9.
    View in: PubMed
    Score: 0.002
  116. The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat. 2001 Dec; 21(4):193-8.
    View in: PubMed
    Score: 0.002
  117. Is suicide contagious? A study of the relation between exposure to the suicidal behavior of others and nearly lethal suicide attempts. Am J Epidemiol. 2001 Jul 15; 154(2):120-7.
    View in: PubMed
    Score: 0.002
  118. Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry. 2001 Jun; 62(6):439-47.
    View in: PubMed
    Score: 0.002
  119. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2001 May; 16(5):499-503.
    View in: PubMed
    Score: 0.002
  120. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics. 2001; 19(5 Pt 1):483-95.
    View in: PubMed
    Score: 0.002
  121. Integration of suicide prevention into outpatient management of bipolar disorder. J Clin Psychiatry. 2001; 62 Suppl 25:3-11.
    View in: PubMed
    Score: 0.002
  122. Alcohol consumption and nearly lethal suicide attempts. Suicide Life Threat Behav. 2001; 32(1 Suppl):30-41.
    View in: PubMed
    Score: 0.002
  123. The influence of geographic mobility on nearly lethal suicide attempts. Suicide Life Threat Behav. 2001; 32(1 Suppl):42-8.
    View in: PubMed
    Score: 0.002
  124. Characteristics of impulsive suicide attempts and attempters. Suicide Life Threat Behav. 2001; 32(1 Suppl):49-59.
    View in: PubMed
    Score: 0.002
  125. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000 Nov; 61(11):841-50.
    View in: PubMed
    Score: 0.002
  126. The Brief Psychiatric Rating Scale as an acute inpatient outcome measurement tool: a pilot study. J Clin Psychiatry. 2000 Jun; 61(6):418-21.
    View in: PubMed
    Score: 0.002
  127. Prolactin response to buspirone was reduced in violent compared to nonviolent parolees. Psychopharmacology (Berl). 1999 Feb; 142(2):144-8.
    View in: PubMed
    Score: 0.001
  128. Stability of diagnosis in bipolar disorder. J Nerv Ment Dis. 1998 Jan; 186(1):17-23.
    View in: PubMed
    Score: 0.001
  129. Identification of nearly fatal suicide attempts: Self-Inflicted Injury Severity Form. Suicide Life Threat Behav. 1998; 28(2):174-86.
    View in: PubMed
    Score: 0.001
  130. Ritanserin in the treatment of cocaine dependence. Biol Psychiatry. 1997 Nov 15; 42(10):932-40.
    View in: PubMed
    Score: 0.001
  131. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res. 1997 Nov 14; 73(1-2):47-56.
    View in: PubMed
    Score: 0.001
  132. Fluvoxamine treatment of trichotillomania. J Clin Psychopharmacol. 1997 Aug; 17(4):278-83.
    View in: PubMed
    Score: 0.001
  133. Behavioral sensitization to cocaine in the absence of altered brain cocaine levels. Pharmacol Biochem Behav. 1997 Aug; 57(4):665-9.
    View in: PubMed
    Score: 0.001
  134. Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjects. Drug Alcohol Depend. 1997 Mar 14; 44(2-3):175-82.
    View in: PubMed
    Score: 0.001
  135. Context-dependent cross-sensitization between cocaine and amphetamine. Life Sci. 1997; 60(1):PL1-7.
    View in: PubMed
    Score: 0.001
  136. Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania. Depress Anxiety. 1997; 6(1):26-30.
    View in: PubMed
    Score: 0.001
  137. Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study. Psychopharmacol Bull. 1997; 33(4):693-9.
    View in: PubMed
    Score: 0.001
  138. Relation of serum valproate concentration to response in mania. Am J Psychiatry. 1996 Jun; 153(6):765-70.
    View in: PubMed
    Score: 0.001
  139. Stability of diagnosis in schizophrenia. Am J Psychiatry. 1996 May; 153(5):682-6.
    View in: PubMed
    Score: 0.001
  140. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacol Bull. 1995; 31(1):103-9.
    View in: PubMed
    Score: 0.001
  141. Suicidality in patients with pure and depressive mania. Am J Psychiatry. 1994 Sep; 151(9):1312-5.
    View in: PubMed
    Score: 0.001
  142. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 1994 Mar 23-30; 271(12):918-24.
    View in: PubMed
    Score: 0.001
  143. Depressive mania associated with nonresponse to antimanic agents. Am J Psychiatry. 1993 Oct; 150(10):1548-51.
    View in: PubMed
    Score: 0.001
  144. Expressive characteristics of anxiety in depressed men and women. J Affect Disord. 1993 Aug; 28(4):267-77.
    View in: PubMed
    Score: 0.001
  145. Compliance with clinic attendance by outpatients with schizophrenia. Hosp Community Psychiatry. 1993 Aug; 44(8):764-7.
    View in: PubMed
    Score: 0.001
  146. A comparison of clinical features in trichotillomania and obsessive-compulsive disorder. Behav Res Ther. 1992 Jan; 30(1):39-44.
    View in: PubMed
    Score: 0.001
  147. Treatment of trichotillomania with fluoxetine. J Clin Psychiatry. 1991 Jun; 52(6):282.
    View in: PubMed
    Score: 0.001
  148. Sociodemographic and prior clinical course characteristics associated with treatment response in depressed patients. J Psychiatr Res. 1988; 22(3):227-37.
    View in: PubMed
    Score: 0.001
  149. Plasma MHPG in untreated panic disorder. Biol Psychiatry. 1987 Dec; 22(12):1491-5.
    View in: PubMed
    Score: 0.001
  150. Patients with panic attacks and abnormal EEG results. Am J Psychiatry. 1987 Apr; 144(4):508-9.
    View in: PubMed
    Score: 0.001
  151. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder. Acta Psychiatr Scand. 1987 Mar; 75(3):243-50.
    View in: PubMed
    Score: 0.001
  152. Diagnosis and treatment of mixed mania. Am J Psychiatry. 1987 Jan; 144(1):96-8.
    View in: PubMed
    Score: 0.001
  153. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects. Arch Gen Psychiatry. 1986 Oct; 43(10):938-47.
    View in: PubMed
    Score: 0.001
  154. Mania. Diagnosis, state measurement and prediction of treatment response. J Affect Disord. 1985 Mar-Apr; 8(2):113-21.
    View in: PubMed
    Score: 0.001
  155. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry. 1984 Mar; 41(3):257-67.
    View in: PubMed
    Score: 0.000
  156. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord. 1983 May; 5(2):103-13.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.